SCHEMBL7646254

SCHEMBL7646254

N#C/[C]=C\c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
TSHR P16473 2/20 0.38
MAOB P27338 2/20 0.38
CYP2A6 P11509 1/20 0.38
MCL1 Q07820 2/20 0.36
LMNA P02545 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TDP1 Q9NUW8 2/20 0.33
GLA P06280 1/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
PKM P14618 1/20 0.33
RAB9A P51151 1/20 0.33
GRIN2D O15399 2/20 0.32
GRIN3B O60391 2/20 0.32
GRIN1 Q05586 2/20 0.32
GRIN2A Q12879 2/20 0.32
GRIN2B Q13224 2/20 0.32
GRIN2C Q14957 2/20 0.32
GRIN3A Q8TCU5 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1514086 1.00 ALDH1A1 (0.38) ALDH1A1TSHRMAOBCYP2A6MCL1
SCHEMBL9383784 1.00 ALDH1A1 (0.38) ALDH1A1TSHRMAOBCYP2A6MCL1
SCHEMBL7716033 0.75 MEN1 (0.50) ALDH1A1TSHRMAOBLMNANPC1
SCHEMBL7716077 0.75 MEN1 (0.50) ALDH1A1TSHRMAOBLMNANPC1
SCHEMBL7716030 0.75 MEN1 (0.50) ALDH1A1TSHRMAOBLMNANPC1
SCHEMBL209325 0.74 ALDH1A1 (0.38) ALDH1A1TSHRMAOBCYP2A6LMNA
SCHEMBL355199 0.73 MAPT (0.55) ALDH1A1NPC1POLBRAB9ACYP19A1
(Z)-1,2-Diphenylethene SCHEMBL27660887 0.72 MAOB (0.55) ALDH1A1MAOBMCL1LMNATRPA1
SCHEMBL366631 0.71 ALDH1A1 (0.45) ALDH1A1TSHRMAOBCYP2A6LMNA
Water SCHEMBL28150278 0.70 ALDH1A1 (0.46) ALDH1A1TSHRMAOBCYP2A6MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3036782-B1 NEW ABSORBER FOR ORGANIC HETEROJUNCTION SOLAR CELLS BASF SE (DE) 2019-10-09 EP claimed
EP-3051946-A1 USE OF SUBSTITUTED DIHYDRO-OXINDOLYL SULFONAMIDES, OR THE SALTS THEREOF, FOR INCREASING THE STRESS TOLERANCE OF PLANTS Bayer CropScience Aktiengesellschaft (DE) 2016-08-10 EP claimed
US-20160211464-A1 NEW ABSORBER FOR ORGANIC HETEROJUNCTION SOLAR CELLS BASF SE (DE) 2016-07-21 US claimed
EP-3036782-A1 NEW ABSORBER FOR ORGANIC HETEROJUNCTION SOLAR CELLS BASF SE (DE) 2016-06-29 EP claimed
WO-2015049351-A1 USE OF SUBSTITUTED DIHYDRO-OXINDOLYL SULFONAMIDES, OR THE SALTS THEREOF, FOR INCREASING THE STRESS TOLERANCE OF PLANTS BAYER CROPSCIENCE AG (DE) 2015-04-09 WO claimed
WO-2015024851-A1 NEW ABSORBER FOR ORGANIC HETEROJUNCTION SOLAR CELLS BASF SE (DE) 2015-02-26 WO claimed
EP-0390693-B1 THIOFORMAMIDE DERIVATIVES RHONE-POULENC SANTE (FR) 1993-08-25 EP claimed
EP-0390693-A1 Thioformamide derivatives RHONE-POULENC SANTE (FR) 1990-10-03 EP claimed
EP-3036782-B1 NEW ABSORBER FOR ORGANIC HETEROJUNCTION SOLAR CELLS BASF SE (DE) 2019-10-09 EP disclosed
US-20160211464-A1 NEW ABSORBER FOR ORGANIC HETEROJUNCTION SOLAR CELLS BASF SE (DE) 2016-07-21 US disclosed
EP-3036782-A1 NEW ABSORBER FOR ORGANIC HETEROJUNCTION SOLAR CELLS BASF SE (DE) 2016-06-29 EP disclosed
WO-2015024851-A1 NEW ABSORBER FOR ORGANIC HETEROJUNCTION SOLAR CELLS BASF SE (DE) 2015-02-26 WO disclosed
US-6486153-B1 Phenylindole derivatives as 5-HT2A receptor ligands MERCK SHARP & DOHME LTD. 2002-11-26 US disclosed
WO-1999011619-A1 PHENYLINDOLE DERIVATIVES AS 5-HT2A RECEPTOR LIGANDS MERCK SHARP & DOHME LIMITED (GB) 1999-03-11 WO disclosed
WO-1994007815-A2 SMALL PEPTIDE ANAPHYLATOXIN RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 1994-04-14 WO disclosed
WO-1994007518-A1 ANAPHYLATOXIN RECEPTOR LIGANDS CONTAINING LIPOPHILIC RESIDUES ABBOTT LABORATORIES (US) 1994-04-14 WO disclosed
US-5246950-A Smooth muscle disorders RHONE-POULENC SANTE (FR) 1993-09-21 US disclosed
EP-0390693-B1 THIOFORMAMIDE DERIVATIVES RHONE-POULENC SANTE (FR) 1993-08-25 EP disclosed
US-5190922-A Antiinflammatory ABBOTT LABORATORIES (US) 1993-03-02 US disclosed
EP-0390693-A1 Thioformamide derivatives RHONE-POULENC SANTE (FR) 1990-10-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160211464-A1 NEW ABSORBER FOR ORGANIC HETEROJUNCTION SOLAR CELLS SLC18A2, EPCAM, SLC18A1 ALDH1A1 195/4885TSHR 4603/4885MAOB 731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.